ARCHIVES

FDA’s Oncologic Drugs Advisory Committee recommended approval of three drugs for cancer, voted down one.

This article is from The Cancer Letter archive.

Vol. 31 No. 33 | September 16, 2005

Download PDF Visit The Full Archive

Related Articles

Grant Review: NIH Names Members To New Clinical Oncology Review Panel

February 26, 1999

Semantics: NIH to Drop “Alternative From Center’s Name; Integrative Better Describes Current Focus

June 6, 2014

With NIH “Accountability” As Background, Advocates Support Budget Increases.

March 30, 2001

House Bill, Report Do Not Include Any Earmarks Or Directives To Aid CCOP, Centers, Cancer Control

August 7, 1987

DeVita Resigns As No. 2 At Sloan-Kettering To “Pursue Clinical Research,” Hospital Says

May 31, 1991

Also in this 12-page issue: NCI gives Doroshow and Fine “lead role” in clinical trials system review.

November 14, 2003